Overview

Gender

male

Hans Bishop is one of our co-founders and has served as Chief Executive Officer since Juno’s inception. He served as an Executive in Residence at Warburg Pincus, a global private equity firm with significant investment experience in the pharmaceutical and healthcare industries.Prior to this, he acted as Executive Vice President and Chief Operating Officer for Dendreon, a Seattle-based biotechnology company that develops immunotherapy products used in cancer treatment. He has served as President of Specialty Medicine at Bayer Healthcare, Senior Vice President of Global Commercial Operations at Chiron Corporation, and Vice President and General Manager of European Biopharmaceuticals.

Mr. Bishop previously held various positions at Glaxo Wellcome and SmithKlineBeecham. He serves on the Board of Directors of Avanir Pharmaceuticals. Mr. Bishop earned a B.S. in chemistry from Brunel University in London.